使用血清蛋白质学的炎症性肠病异质性的表征:一个多中心研究
Benita Salomon1, Padhmanand Sudhakar2,3, Daniel Bergemalm4
1Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
Journal of Crohn's & colitis
|November 4, 2024
概括
炎症性肠病 (IBD) 亚型,克罗恩病 (CD) 和性结肠炎 (UC),存在于连续的频谱上. 血清蛋白质分析显示,结肠CD更像UC,而不是阴茎CD.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 遗传和转录基因数据需要改善炎症性肠病 (IBD) 的分子特征.
- 蛋白质组学通过捕捉转录后修饰,为IBD表型提供了先进的见解.
研究的目的:
- 用血清蛋白来评估炎症性肠病 (IBD) 谱.
- 在欧洲队列中识别IBD内的生物亚型.
主要方法:
- 使用近距离延伸方法测量了1551名IBD患者和312名对照患者的86种与炎症相关的血清蛋白.
- 在IBD亚型之间以及IBD和健康对照之间的蛋白质水平显著不同时进行选.
- 采用分类模型来探索IBD频谱,基于区分克罗恩病 (CD) 和性结肠炎 (UC) 的概率得分.
主要成果:
- 多种蛋白质在阴茎和结肠IBD之间存在显著差异.
- 在连续光谱上确定了一种血清蛋白质签名,将结肠CD定位在UC和阴茎CD之间.
- 分类模型区分UC与阴道CD (AUC > 0.73) 优于结肠CD (AUC < 0.62),结肠CD与阴道CD (AUC 0.67-0.69) 的性能中间.
结论:
- 血清蛋白发现支持连续IBD频谱,挑战CD和UC的清晰分离.
- 疾病的位置,而不是CD与UC,可能会定义疾病相似性,结肠CD更像UC,而不是阴茎CD.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
321
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
321
01:30Inflammatory Bowel Disease II: Crohn's Disease
188
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
188
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
145
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
145
01:29Inflammatory Bowel Disease IV: Pharmacological Management
116
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
116
01:17Chronic Bowel Disorders: Introduction
390
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
390
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117